IMARA ROCE Ratio 2011-2026 | IMRA

Annual ROCE Ratio IMARA

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-26.04	-33.74	-33.97	50.49	-59.8	-49.29	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
50.49	-59.8	-25.39

Quarterly ROCE Ratio IMARA

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-31.5	-35.62	-37.83	-25.63	-34.9	-34.78	-33.92	-22.11	-6.06	19.26	41.84	48.56	34.81	5.01	-30.61	-47.61	-62.41	-63.46	-55.39	-35.71	-21.62	7.27	30.85	34.05	34.05	19.96	8.59	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
48.56	-63.46	-10.92

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
Amneal Pharmaceuticals AMRX	14.49	$ 12.32	-	$ 3.86 B	USA
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
argenx SE ARGX	-211.69	$ 765.43	-	$ 25 B	Niderland
AlloVir ALVR	-58.56	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	394.73	-	-	$ 8.42 M	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	-6.45	$ 23.27	-	$ 2.96 B	USA
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
BioNTech SE BNTX	-4.81	$ 89.62	-	$ 27.2 B	Germany
Autolus Therapeutics plc AUTL	-151.88	$ 1.36	-	$ 362 M	Britain
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	11.12	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Burford Capital Limited BUR	14.24	$ 4.54	-	$ 764 M	Britain
Cabaletta Bio CABA	-153.72	$ 3.07	-	$ 308 M	USA
BeiGene, Ltd. BGNE	7.03	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	-104.38	$ 3.76	-	$ 9.05 B	Australia
CymaBay Therapeutics CBAY	-34.79	-	-	$ 3.45 B	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	-115.03	$ 3.03	-	$ 6.59 B	Israel
Aytu BioScience AYTU	-12.81	$ 2.57	-3.38 %	$ 16.1 M	USA
Avid Bioservices CDMO	-30.68	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	-107.83	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Checkpoint Therapeutics CKPT	444.94	-	-	$ 169 M	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	-88.5	-	-	$ 231 M	USA
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	-69.06	-	-	$ 401 M	USA
Cellectar Biosciences CLRB	-269.17	$ 2.75	-	$ 7.17 M	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	453.99	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	-123.17	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	-60.12	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	-0.69	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	-57.84	$ 9.71	-	$ 129 M	USA
Curis CRIS	-104.6	$ 0.55	0.09 %	$ 7.24 M	USA
Coherus BioSciences CHRS	-296.87	$ 1.67	-	$ 196 M	USA